KASRA KIAROSTAMI

Detail-oriented Animal Research Specialist with a proven track record in procurement and management of materials critical for animal research projects. Demonstrated expertise in overseeing the care of pigs while ensuring strict compliance with ethical standards and protocols. Skilled in preparing pig models with precision through the establishment of Swan-Ganz, arterial, and urinary catheters, as well as conducting advanced biofilm analyses using scanning electron and confocal microscopy. Adept at maintaining comprehensive project databases to support accurate documentation and effective tracking of research objectives.

• Curs de Formació del Personal Usuari d’Animals d’Experimentació per a les Funcions de Cura, Eutanàsia, Realització de Procediments, i Disseny de Projectes i Procediments (funcions a, b, c i d) en Rosegadors i Porcí
• ISICIP 2023 ( poster certification)
• ERS INTERNATIONAL CONGRESS 2022 (orarl presentation)/ The efficacy of telavancin in comparison to linezolid on endotracheal tube biofilm in pigs with MRSA pneumonia

1. Rovira N, Cillóniz C, López-Aladid R, Torres A. Inflammatory and cardiac phenotypes are predictors for complications and outcomes in hospitalized COVID-19 patients. ERS Congress 2024 Abstracts.October 2024.

2. Ceccato A, Forne C, Bos LD, Zapatero A. Clustering COVID-19 ARDS patients through the first days of ICU admission: An analysis of the CIBERESUCICOVID cohort. Crit Care. 2024 Mar;28(1):48. doi:10.1186/s13054-024-04876-5.

3. Kiarostami K, Fernández-Barat L, Battaglini D, Torres A. The efficacy of telavancin in comparison with linezolid on endotracheal tube biofilm in pigs with methicillin-resistant Staphylococcus aureuspneumonia. Int J Antimicrob Agents. 2023 Dec;63(2):107052. doi:10.1016/j.ijantimicag.2023.107052.

4. Fernández-Barat L, Soler Comas A, López-Aladid R, Torres A. Engineered live bacteria as a new therapy for P. aeruginosabiofilms in ventilator-associated pneumonia. ERS International Congress 2023 Abstracts. October 2023.

5. Rovira N, Cillóniz C, López-Aladid R, Torres A. Levels of inflammatory and cardiac biomarkers as a predictor factor for complications and outcomes in hospitalized COVID-19 patients. ERS International Congress 2023 Abstracts. October 2023.

6. Galli F, Bindo F, Motos A, Santacoloma B. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients. Intensive Care Med. 2023 Jul;49(8):923-930. doi:10.1007/s00134-023-07161-1.

7. Barbeta E, Arrieta M, Motos A, Torres A. A long-lasting porcine model of ARDS caused by pneumonia and ventilator-induced lung injury. Crit Care. 2023 Jun;27(1):185. doi:10.1186/s13054-023-04512-8.

8. Motos A, Yang H, Li Bassi G, Torres A. Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia. Crit Care. 2023 Feb;27(1):70. doi:10.1186/s13054-023-04331-x.

9. Kiarostami K, Battaglini D, Motos A, Torres A. The efficacy of telavancin in comparison to linezolid on endotracheal tube biofilm in pigs with MRSA pneumonia. ERS International Congress 2022 Abstracts.December 2022.

10. Torres A, Motos A, Cillóniz C, Santacoloma B. Major candidate variables to guide personalized treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study. Intensive Care Med. 2022 Jun;48(7):827-837. doi:10.1007/s00134-022-06726-w.

11. Torres A, Motos A, Ceccato A, Barbé F. Methodology of a large multicenter observational study of patients with COVID-19 in Spanish intensive care units. Arch Bronconeumol. 2022 Apr;58(4):327-333. doi:10.1016/j.arbres.2022.03.010.

12. Ceccato A, Pérez-Arnal R, Motos A, Vidal Cortés P. One-year mortality after ICU admission due to COVID-19 infection. Intensive Care Med. 2022 Jan;48(3):298-309. doi:10.1007/s00134-021-06611-y.

13. Torres A, Motos A, Riera J, Zapatero A. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients. Crit Care. 2021 Dec;25(1):408. doi:10.1186/s13054-021-03849-2.

14. Torres A, Motos A, Riera J, Zapatero A. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients. Crit Care. 2021 Dec;25(1):361. doi:10.1186/s13054-021-03727-x.